Ipratropium bromide/salbutamol, sold under the brand name Combivent among others, is a combination medication used to treat chronic obstructive pulmonary disease (COPD).
[1] Common side effects include sore throat, muscle cramps, and nausea.
[1] Other side effects may include bronchospasm, allergic reactions, and upper respiratory tract infections.
[4] In 2022, it was the 178th most commonly prescribed medication in the United States, with more than 2 million prescriptions.
[10] Since Combivent contains a chlorofluorocarbon-based propellant, its use was discontinued in 2013 in the United States and other countries.